Health & Environmental Research Online (HERO)


Print Feedback Export to File
2064196 
Journal Article 
Review 
Evaluation of the carcinogenicity of inorganic arsenic 
Cohen, SM; Arnold, LL; Beck, BD; Lewis, AS; Eldan, M 
2013 
Yes 
Critical Reviews in Toxicology
ISSN: 1040-8444
EISSN: 1547-6898 
43 
711-752 
English 
Inorganic arsenic (iAs) at high exposures is a human carcinogen, affecting mainly the urinary bladder, lung and skin. We present an assessment of the mode of action (MOA) of iAs's carcinogenicity based on the United States Environmental Protection Agency/International Programme on Chemical Safety (USEPA/IPCS) framework, focusing primarily on bladder cancer. Evidence is presented for a MOA involving formation of reactive trivalent metabolites interacting with critical cellular sulfhydryl groups, leading to cytotoxicity and regenerative cell proliferation. Metabolism, kinetics, cell transport, and reaction with specific proteins play a critical role in producing the effects at the cellular level, regardless of cell type, whether urothelium, lung epithelium or epidermis. The cytotoxicity induced by iAs results in non-cancer toxicities, and the regenerative cell proliferation enhances development of epithelial cancers. In other tissues, such as vascular endothelium, different toxicities develop, not cancer. Evidence supporting this MOA comes from in vitro investigations on animal and human cells, from animal models, and from epidemiological studies. This MOA implies a non-linear, threshold dose-response relationship for both non-cancer and cancer end points. The no effect levels in animal models (approximately 1 ppm of water or diet) and in vitro (>0.1 µM trivalent arsenicals) are strikingly consistent. Cancer effects of iAs in humans generally are not observed below exposures of 100-150 ppb in drinking water: below these exposures, human urine concentrations of trivalent metabolites are generally below 0.1 µM, a concentration not associated with bladder cell cytotoxicity in in vitro or animal models. Environmental exposures to iAs in most of the United States do not approach this threshold. 
Arsenic; bladder; cell proliferation; cytotoxicity; epidemiology; lung; skin 
• Arsenic Hazard ID
          PubMed
          ToxNet
          Considered New
          PubMed
          WOS
          ToxNet
          Excluded
               Toxnet Duplicates
          ToxNet
          Excluded
               Toxnet Duplicates
          ToxNet
          Excluded
               Reviews
               Toxnet Duplicates
     2. Lit Search Updates through Oct 2015
          PubMed
          WOS
          ToxNet
          Initial Filter
               Reviews
          Considered
     7. Other Studies through Oct 2015
          Review/Risk Assessment/Guidance document
          Not Relevant
• Arsenic (Inorganic)
     1. Literature
          Lit search updates through Oct 2015
     Cited in Volume 1
• Arsenic Susceptibility
     1. Susceptibility Literature Screening
          Supplemental Search
     2. Excluded
          Not Relevant
     Life Stages Citation Mapping
          Top 5%